DexCom, Inc. DXCM recently announced positive results from its CONNECT randomized controlled trial, demonstrating that use of ...

Shares of DexCom Inc. rose 5.16% to $76.62 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.30% to 7,405.73 and the Dow Jones ...

DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the continuous glucose monitoring (CGM) market. A strong preliminary fourth-quarter ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

(Nasdaq: DXCM), the global leader in glucose biosensing, announced today through ongoing quality and accounting reviews it recently identified certain lots of Dexcom G7 sensors originally designated ...

SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter ...

DXCM stock jumps on Q1 beat as revenues rise 15% and margins expand, with strong CGM demand and raised profitability outlook boosting momentum.

We recently published a list of 12 High Growth Large Cap Stocks to Buy Now. In this article, we are going to take a look at where DexCom, Inc. (NASDAQ:DXCM) stands against other high growth large cap ...

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose biosensing, today announced the promotion of Jake Leach to president, in addition to his ...

We recently published a list of What Propelled These 10 Firms’ Double-Digit Gains? In this article, we are going to take a look at where DexCom, Inc. (NASDAQ:DXCM) stands against other Friday’s top ...

DexCom, Inc. DXCM is well-positioned for growth in the coming quarters, supported by the significant potential of the ...